Repro Med Systems Inc
NASDAQ:KRMD
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.03
2.99
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one KRMD stock under the Base Case scenario is 3.16 USD. Compared to the current market price of 2.68 USD, Repro Med Systems Inc is Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Repro Med Systems Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for KRMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Repro Med Systems Inc
Balance Sheet Decomposition
Repro Med Systems Inc
Current Assets | 20.3m |
Cash & Short-Term Investments | 11.5m |
Receivables | 4.1m |
Other Current Assets | 4.7m |
Non-Current Assets | 8.2m |
PP&E | 7.4m |
Intangibles | 754.4k |
Other Non-Current Assets | 99k |
Current Liabilities | 4.5m |
Accounts Payable | 975.2k |
Accrued Liabilities | 2.5m |
Short-Term Debt | 314.3k |
Other Current Liabilities | 622.1k |
Non-Current Liabilities | 3.7m |
Long-Term Debt | 316.6k |
Other Non-Current Liabilities | 3.3m |
Earnings Waterfall
Repro Med Systems Inc
Revenue
|
28.5m
USD
|
Cost of Revenue
|
-11.8m
USD
|
Gross Profit
|
16.7m
USD
|
Operating Expenses
|
-27m
USD
|
Operating Income
|
-10.3m
USD
|
Other Expenses
|
-3.5m
USD
|
Net Income
|
-13.7m
USD
|
Free Cash Flow Analysis
Repro Med Systems Inc
USD | |
Free Cash Flow | USD |
KORU Medical Systems reported Q2 2024 revenues of $8.4 million, a 22% increase year-over-year. The core business grew by 20%, driven by SCIg market growth and geographic expansion. Success in their Novel Therapies pipeline, including a Phase III trial for a nephrology drug and regulatory clearance for the FreedomEdge Infusion System in Japan, boosted international growth by 46%. Operations improvements and higher gross margins reduced losses, steering towards breakeven cash flow by Q4. Updated 2024 guidance predicts revenues of $32-32.5 million and gross margins of 61-62%, reflecting strong market performance despite expected normalization in international sales.
What is Earnings Call?
KRMD Profitability Score
Profitability Due Diligence
Repro Med Systems Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Repro Med Systems Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
KRMD Solvency Score
Solvency Due Diligence
Repro Med Systems Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Repro Med Systems Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KRMD Price Targets Summary
Repro Med Systems Inc
According to Wall Street analysts, the average 1-year price target for KRMD is 3.67 USD with a low forecast of 3.03 USD and a high forecast of 4.2 USD.
Dividends
Current shareholder yield for KRMD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
KRMD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.
Contact
IPO
Employees
Officers
The intrinsic value of one KRMD stock under the Base Case scenario is 3.16 USD.
Compared to the current market price of 2.68 USD, Repro Med Systems Inc is Undervalued by 15%.